Recent Additions

This page includes the documents that were newly added to the repository within the last 30 days.

All these words:

This exact word or phrase:

Any of these words:

None of these words:

Language:

Visit our Help Page for additional assistance

Select a Range:

Select a Format:

Custom Search Builder:

Custom Search Box

Visit our Help Page for additional assistance

Showing 341 - 360 of 1970 results

'I Just Don't Want Them to Be my Patient Again': an Exploratory Mixed-methods Study Examining Provider Home Safety Concerns For Adolescents With Acquired Brain Injuries in the US Midwest.

Anderson, Sarah E. ;

Schroedle, S.

March 2026 | Injury Prevention : Journal of the International Society for Child and Adolescent Injury Prevention, 2026, v. 32, no. 2

Adolescents with acquired brain injuries are at risk for additional injuries after hospital discharge. We asked healthcare providers to identify and prioritise urgent hazards in the home setting for this population.We used a convergent mixed methods approach. Healthcare providers who do discharge planning and community re-integration for adolescent ...

10/09/2026

Supporting Files

Title : 'I Just Don't Want Them to Be my Patient Again': an Exploratory Mixed-methods Study Examining Provider Home Safety Concerns For Adolescents With Acquired Brain Injuries in the US Midwest. Personal Author(s) : Anderson, Sarah E.;Schroedle, S.;Stamper, T.;Lundine, J. P.;Patterson, E. S.;DiGiovine, C. P.;Swearingen, S.;Wengerd, L. R.;Darragh, A. R.; Published Date : March 2026 Pages in Document : 309-316 (18 pdf pages) Source : Injury Prevention : Journal of the International Society for Child and Adolescent Injury Prevention, 2026, v. 32, no. 2 DOI : https://doi.org/10.1136/ip-2024-045326 Journal Title : Injury Prevention : Journal of the International Society for Child and Adolescent Injury Prevention
Anderson, S. E., Schroedle, S., Stamper, T., Lundine, J. P., Patterson, E. S., DiGiovine, C. P., Swearingen, S., Wengerd, L. R., & Darragh, A. R. (2026). 'I Just Don't Want Them to Be my Patient Again': an Exploratory Mixed-methods Study Examining Provider Home Safety Concerns For Adolescents With Acquired Brain Injuries in the US Midwest. Injury Prevention : Journal of the International Society for Child and Adolescent Injury Prevention, 32(2). https://doi.org/10.1136/ip-2024-045326

Anderson, Sarah E., S. Schroedle, T. Stamper, J. P. Lundine, E. S. Patterson, C. P. DiGiovine, S. Swearingen, L. R. Wengerd, and A. R. Darragh. "'I Just Don't Want Them to Be my Patient Again': an Exploratory Mixed-methods Study Examining Provider Home Safety Concerns For Adolescents With Acquired Brain Injuries in the US Midwest." Injury Prevention : Journal of the International Society for Child and Adolescent Injury Prevention 32, no. 2 (2026). https://doi.org/10.1136/ip-2024-045326.

Anderson, Sarah E., et al. "'I Just Don't Want Them to Be my Patient Again': an Exploratory Mixed-methods Study Examining Provider Home Safety Concerns For Adolescents With Acquired Brain Injuries in the US Midwest." Injury Prevention : Journal of the International Society for Child and Adolescent Injury Prevention, vol. 32, no. 2, 2026. Stacks. https://doi.org/10.1136/ip-2024-045326.
Export RIS Citation Information. TY - Journal Article AU - Anderson, Sarah E. AU - Schroedle, S. AU - Stamper, T. AU - Lundine, J. P. AU - Patterson, E. S. AU - DiGiovine, C. P. AU - Swearingen, S. AU - Wengerd, L. R. AU - Darragh, A. R. AB - Adolescents with acquired brain injuries are at risk for additional injuries after hospital discharge. We asked healthcare providers to identify and prioritise urgent hazards in the home setting for this population. AB - We used a convergent mixed methods approach. Healthcare providers who do discharge planning and community re-integration for adolescent patients with brain injury were recruited from hospitals in the US Midwest. Participants completed two structured surveys, semi-structured interviews and a Hazard Prioritisation Matrix Activity. We analysed quantitative data via descriptive statistics and qualitative data via inductive thematic analysis to identify hazards, urgency, interactive themes and generate a conceptual model. AB - All participants validated four preidentified hazards in the surveys and the interviews: slippery objects on the floor, large furniture/objects in the path of travel, unattended open flames and inappropriate use of cooking appliances. 59 hazards were self-identified during the Hazard Priority Matrix Activity and assigned an urgency rating, with 12 (20.3%) urgent, 20 (33.9%) major, 19 (32.2%) moderate and 8 (13.6%) minor risks. We identified seven interactive themes about hazard factors: hazardous activities, hazardous situations, hazardous objects, hazardous others, hazardous spaces, harms and client factors. A conceptual model for home safety concerns links hazards, risks and harms. AB - Adolescents with acquired brain injuries need healthcare providers to recognise unique and complex hazards in their homes that could lead to harm. Mitigating home hazards may prevent additional unintentional injury for these adolescents. More research is needed to generalise this information for this population across clinical settings. AB - NCT04768946. AB - Author manuscript AN - cdc:261926 C4 - PMC12065924 DO - https://doi.org/10.1136/ip-2024-045326 IS - 2 J2 - Injury Prevention : Journal of the International Society for Child and Adolescent Injury Prevention KW - Adolescent KW - Female KW - Brain Injuries KW - Patient Discharge KW - Qualitative Research KW - Male KW - Humans KW - Health Personnel KW - Accidents, Home KW - traumatic brain injury KW - adolescent KW - risk perception KW - mixed methods KW - rehabilitation KW - Humans KW - Adolescent KW - Male KW - Female KW - Brain Injuries KW - Accidents, Home KW - Qualitative Research KW - Patient Discharge KW - Health Personnel LA - eng PY - 2026 T2 - Injury Prevention : Journal of the International Society for Child and Adolescent Injury Prevention T2 - Injury Prevention : Journal of the International Society for Child and Adolescent Injury Prevention, 2026, v. 32, no. 2 TI - 'I Just Don't Want Them to Be my Patient Again': an Exploratory Mixed-methods Study Examining Provider Home Safety Concerns For Adolescents With Acquired Brain Injuries in the US Midwest. VL - 32 UR - https://stacks.cdc.gov/view/cdc/261926 ER -
Engaging Low-Wage Workers in Health and Well-Being Survey Research: Strategies From 5 Occupational Studies.

Sabbath, Erika L. ;

Lovejoy, Meg

February 2025 | American Journal of Public Health, 2025, v. 115, no. 2

Without perspectives of low-wage workers in studies of worker health and well-being, researchers cannot comprehensively assess occupational health and health equity impacts of workplace exposures and interventions. Researchers and practitioners have noted particular challenges in engaging low-wage workers in worksite-based health survey research, y ...

10/09/2026

Supporting Files

Title : Engaging Low-Wage Workers in Health and Well-Being Survey Research: Strategies From 5 Occupational Studies. Personal Author(s) : Sabbath, Erika L.;Lovejoy, Meg;Schneider, Daniel K.;Diaz-Linhart, Yaminette;DeHorn, Grace;Peters, Susan E.; Published Date : February 2025 Pages in Document : 201-208 (13 pdf pages) Source : American Journal of Public Health, 2025, v. 115, no. 2 DOI : https://doi.org/10.2105/AJPH.2024.307875 Journal Title : American Journal of Public Health
Sabbath, E. L., Lovejoy, M., Schneider, D. K., Diaz-Linhart, Y., DeHorn, G., & Peters, S. E. (2025). Engaging Low-Wage Workers in Health and Well-Being Survey Research: Strategies From 5 Occupational Studies. American Journal of Public Health, 115(2). https://doi.org/10.2105/AJPH.2024.307875

Sabbath, Erika L., Meg Lovejoy, Daniel K. Schneider, Yaminette Diaz-Linhart, Grace DeHorn, and Susan E. Peters. "Engaging Low-Wage Workers in Health and Well-Being Survey Research: Strategies From 5 Occupational Studies." American Journal of Public Health 115, no. 2 (2025). https://doi.org/10.2105/AJPH.2024.307875.

Sabbath, Erika L., et al. "Engaging Low-Wage Workers in Health and Well-Being Survey Research: Strategies From 5 Occupational Studies." American Journal of Public Health, vol. 115, no. 2, 2025. Stacks. https://doi.org/10.2105/AJPH.2024.307875.
Export RIS Citation Information. TY - Journal Article AU - Sabbath, Erika L. AU - Lovejoy, Meg AU - Schneider, Daniel K. AU - Diaz-Linhart, Yaminette AU - DeHorn, Grace AU - Peters, Susan E. AB - Without perspectives of low-wage workers in studies of worker health and well-being, researchers cannot comprehensively assess occupational health and health equity impacts of workplace exposures and interventions. Researchers and practitioners have noted particular challenges in engaging low-wage workers in worksite-based health survey research, yet little scholarship has described strategies for improving their engagement and response rates. To fill this gap, we present case examples from 5 occupational studies conducted between 2020 and 2024 in industries including health care, food service, and fulfillment centers. For each case, we describe how we identified barriers to worker engagement in surveys, explain specific strategies we used to address those barriers, and assess the effectiveness of these actions. Then, summarizing across case examples, we offer practical recommendations to researchers surveying low-wage populations, highlighting that high-touch recruitment, building trust with workers and managers, and obtaining manager support to take surveys during work time (for worksite-based studies) are critical for obtaining reliable, representative data. Our work contributes to broader discussions on improving survey response rates in vulnerable worker populations and aims to support future researchers undertaking similar efforts. ( AB - . 2025;115(2):201-208. https://doi.org/10.2105/AJPH.2024.307875). AB - Author manuscript AN - cdc:261925 C4 - PMC11715568 DO - https://doi.org/10.2105/AJPH.2024.307875 IS - 2 J2 - American Journal of Public Health KW - Humans KW - Poverty KW - Workplace KW - Occupational Health KW - Health Surveys KW - Salaries and Fringe Benefits KW - Humans KW - Occupational Health KW - Workplace KW - Health Surveys KW - Salaries and Fringe Benefits KW - Poverty LA - eng PY - 2025 T2 - American Journal of Public Health T2 - American Journal of Public Health, 2025, v. 115, no. 2 TI - Engaging Low-Wage Workers in Health and Well-Being Survey Research: Strategies From 5 Occupational Studies. VL - 115 UR - https://stacks.cdc.gov/view/cdc/261925 ER -
Trends in the Incidence of Young-adult-onset Diabetes by Diabetes Type: a Multi-national Population-based Study From an International Diabetes Consortium.

Magliano, Dianna J ;

Chen, Lei

December 2024 | The Lancet. Diabetes & Endocrinology, 2024, v. 12, no. 12

Population-based incidence data on young-adult-onset type 1 diabetes and type 2 diabetes are limited. We aimed to examine secular trends in the incidence of diagnosed type 1 diabetes and type 2 diabetes with an age of onset between 15 and 39 years.In this multicountry aggregate data analysis, we assembled eight administrative datasets from high-inc ...

10/09/2026

Supporting Files

Title : Trends in the Incidence of Young-adult-onset Diabetes by Diabetes Type: a Multi-national Population-based Study From an International Diabetes Consortium. Personal Author(s) : Magliano, Dianna J;Chen, Lei;Morton, Jedidiah I;Salim, Agus;Carstensen, Bendix;Gregg, Edward W;Pavkov, Meda E;Arffman, Martti;Colhoun, Helen M;Ha, Kyoung Hwa;Imamura, Tomoaki;Jermendy, György;Kim, Dae Jung;Kiss, Zoltán;Mauricio, Didac;McGurnaghan, Stuart J;Nishioka, Yuichi;Wild, Sarah H;Winell, Klas;Shaw, Jonathan E; Published Date : December 2024 Pages in Document : 915-923 (18 pdf pages) Source : The Lancet. Diabetes & Endocrinology, 2024, v. 12, no. 12 DOI : https://doi.org/10.1016/S2213-8587(24)00243-2 Journal Title : The Lancet. Diabetes & Endocrinology
Magliano, D. J., Chen, L., Morton, J. I., Salim, A., Carstensen, B., Gregg, E. W., Pavkov, M. E., Arffman, M., Colhoun, H. M., Ha, K. H., Imamura, T., Jermendy, G., Kim, D. J., Kiss, Z., Mauricio, D., McGurnaghan, S. J., Nishioka, Y., Wild, S. H., Winell, K., & Shaw, J. E. (2024). Trends in the Incidence of Young-adult-onset Diabetes by Diabetes Type: a Multi-national Population-based Study From an International Diabetes Consortium. The Lancet. Diabetes & Endocrinology, 12(12). https://doi.org/10.1016/S2213-8587(24)00243-2

Magliano, Dianna J, Lei Chen, Jedidiah I Morton, Agus Salim, Bendix Carstensen, Edward W Gregg, and Meda E Pavkov, et al.. "Trends in the Incidence of Young-adult-onset Diabetes by Diabetes Type: a Multi-national Population-based Study From an International Diabetes Consortium." The Lancet. Diabetes & Endocrinology 12, no. 12 (2024). https://doi.org/10.1016/S2213-8587(24)00243-2.

Magliano, Dianna J, et al. "Trends in the Incidence of Young-adult-onset Diabetes by Diabetes Type: a Multi-national Population-based Study From an International Diabetes Consortium." The Lancet. Diabetes & Endocrinology, vol. 12, no. 12, 2024. Stacks. https://doi.org/10.1016/S2213-8587(24)00243-2.
Export RIS Citation Information. TY - Journal Article AU - Magliano, Dianna J AU - Chen, Lei AU - Morton, Jedidiah I AU - Salim, Agus AU - Carstensen, Bendix AU - Gregg, Edward W AU - Pavkov, Meda E AU - Arffman, Martti AU - Colhoun, Helen M AU - Ha, Kyoung Hwa AU - Imamura, Tomoaki AU - Jermendy, György AU - Kim, Dae Jung AU - Kiss, Zoltán AU - Mauricio, Didac AU - McGurnaghan, Stuart J AU - Nishioka, Yuichi AU - Wild, Sarah H AU - Winell, Klas AU - Shaw, Jonathan E AB - Population-based incidence data on young-adult-onset type 1 diabetes and type 2 diabetes are limited. We aimed to examine secular trends in the incidence of diagnosed type 1 diabetes and type 2 diabetes with an age of onset between 15 and 39 years. AB - In this multicountry aggregate data analysis, we assembled eight administrative datasets from high-income jurisdictions and countries (Australia, Denmark, Finland, Hungary, Japan, Scotland, South Korea, and Spain [Catalonia]) that had appropriate data available from an international diabetes consortium (GLOBODIAB) describing incidence by diabetes type among people aged 15-39 years from 2000 to 2020. We modelled type 1 diabetes and type 2 diabetes incidence rates using Poisson regression including age and calendar time by sex. AB - During the years 2000-20, there were 349 591 incident diabetes (both types) cases from 346 million person-years of follow-up among people aged 15-39 years. Over time, there was no statistically significant change in the incidence of type 1 diabetes in Hungary and Japan. The incidence of type 1 diabetes significantly increased in Australia, Denmark, Finland, Scotland, South Korea, and Spain, with annual changes ranging from 0·5% to 6·0%. The incidence of type 2 diabetes significantly increased in four of eight jurisdictions (Denmark, Finland, Japan, and South Korea), with annual increases from 2·0% to 8·5%. The magnitude of increase in incidence of type 2 diabetes was greater in Asian than non-Asian jurisdictions. There was no statistically significant change in type 2 diabetes incidence in Australia and Hungary. The incidence of type 2 diabetes significantly decreased in Scotland and Spain, with annual changes of -0·7% and -1·5%, respectively. AB - There is variability in the trajectory of the incidence of young-adult-onset type 2 diabetes among high-income countries or jurisdictions, with a greater evidence of increase in Asian than non-Asian countries. Evolving trends in the incidence of type 1 and type 2 diabetes in young adults call for the ongoing surveillance of diabetes incidence and a greater research focus on this population. AB - US Centers for Disease Control and Prevention, Diabetes Australia Research Programme, and Victoria State Government Operational Infrastructure Support Programme. AB - Author manuscript AN - cdc:261924 C4 - PMC11812581 DO - https://doi.org/10.1016/S2213-8587(24)00243-2 IS - 12 J2 - The Lancet. Diabetes & Endocrinology KW - Diabetes Mellitus, Type 2 KW - Diabetes Mellitus, Type 1 KW - Adolescent KW - Female KW - Incidence KW - Male KW - Age of Onset KW - Humans KW - Young Adult KW - Adult KW - Humans KW - Incidence KW - Adolescent KW - Adult KW - Male KW - Young Adult KW - Female KW - Diabetes Mellitus, Type 2 KW - Diabetes Mellitus, Type 1 KW - Age of Onset LA - eng PY - 2024 T2 - The Lancet. Diabetes & Endocrinology T2 - The Lancet. Diabetes & Endocrinology, 2024, v. 12, no. 12 TI - Trends in the Incidence of Young-adult-onset Diabetes by Diabetes Type: a Multi-national Population-based Study From an International Diabetes Consortium. VL - 12 UR - https://stacks.cdc.gov/view/cdc/261924 ER -
Meeting Report of the 37th International Conference on Antiviral Research in Gold Coast, Australia, May 20-24, 2024, Organized by the International Society For Antiviral Research.

Welch, Stephen R. ;

Bilello, John P.

December 2024 | Antiviral Research, 2024, v. 232

The 37th International Conference on Antiviral Research (ICAR) was held in Gold Coast, Australia, May 20-24, 2024. ICAR 2024 featured over 75 presentations along with two poster sessions and special events, including those specifically tailored for trainees and early-career scientists. The meeting served as a platform for the exchange of cutting-ed ...

10/09/2026

Supporting Files

Title : Meeting Report of the 37th International Conference on Antiviral Research in Gold Coast, Australia, May 20-24, 2024, Organized by the International Society For Antiviral Research. Personal Author(s) : Welch, Stephen R.;Bilello, John P.;Carter, Kara;Delang, Leen;Dirr, Larissa;Durantel, David;Feng, Joy Y.;Gowen, Brian B.;Herrero, Lara J.;Janeba, Zlatko;Kleymann, Gerald;Lee, Alpha A.;Meier, Chris;Moffat, Jennifer;Schang, Luis M.;Schiffer, Joshua T.;Seley-Radtke, Katherine L.;Sheahan, Timothy P.;Spengler, Jessica R.; Published Date : December 2024 Pages in Document : 106037 (85 pdf pages) Source : Antiviral Research, 2024, v. 232 DOI : https://doi.org/10.1016/j.antiviral.2024.106037 Journal Title : Antiviral Research
Welch, S. R., Bilello, J. P., Carter, K., Delang, L., Dirr, L., Durantel, D., Feng, J. Y., Gowen, B. B., Herrero, L. J., Janeba, Z., Kleymann, G., Lee, A. A., Meier, C., Moffat, J., Schang, L. M., Schiffer, J. T., Seley-Radtke, K. L., Sheahan, T. P., & Spengler, J. R. (2024). Meeting Report of the 37th International Conference on Antiviral Research in Gold Coast, Australia, May 20-24, 2024, Organized by the International Society For Antiviral Research. Antiviral Research, 232. https://doi.org/10.1016/j.antiviral.2024.106037

Welch, Stephen R., John P. Bilello, Kara Carter, Leen Delang, Larissa Dirr, David Durantel, and Joy Y. Feng, et al.. "Meeting Report of the 37th International Conference on Antiviral Research in Gold Coast, Australia, May 20-24, 2024, Organized by the International Society For Antiviral Research." Antiviral Research 232 (2024). https://doi.org/10.1016/j.antiviral.2024.106037.

Welch, Stephen R., et al. "Meeting Report of the 37th International Conference on Antiviral Research in Gold Coast, Australia, May 20-24, 2024, Organized by the International Society For Antiviral Research." Antiviral Research, vol. 232, 2024. Stacks. https://doi.org/10.1016/j.antiviral.2024.106037.
Export RIS Citation Information. TY - Journal Article AU - Welch, Stephen R. AU - Bilello, John P. AU - Carter, Kara AU - Delang, Leen AU - Dirr, Larissa AU - Durantel, David AU - Feng, Joy Y. AU - Gowen, Brian B. AU - Herrero, Lara J. AU - Janeba, Zlatko AU - Kleymann, Gerald AU - Lee, Alpha A. AU - Meier, Chris AU - Moffat, Jennifer AU - Schang, Luis M. AU - Schiffer, Joshua T. AU - Seley-Radtke, Katherine L. AU - Sheahan, Timothy P. AU - Spengler, Jessica R. AB - The 37th International Conference on Antiviral Research (ICAR) was held in Gold Coast, Australia, May 20-24, 2024. ICAR 2024 featured over 75 presentations along with two poster sessions and special events, including those specifically tailored for trainees and early-career scientists. The meeting served as a platform for the exchange of cutting-edge research, with presentations and discussions covering novel antiviral compounds, vaccine development, clinical trials, and therapeutic advancements. A comprehensive array of topics in antiviral science was covered, from the latest breakthroughs in antiviral drug development to innovative strategies for combating emerging viral threats. The keynote presentations provided fascinating insight into two diverse areas fundamental to medical countermeasure development and use, including virus emergence at the human-animal interface and practical considerations for bringing antivirals to the clinic. Additional sessions addressed a variety of timely post-pandemic topics, such as the hunt for broad spectrum antivirals, combination therapy, pandemic preparedness, application of in silico tools and AI in drug discovery, the virosphere, and more. Here, we summarize all the presentations and special sessions of ICAR 2024 and introduce the 38th ICAR, which will be held in Las Vegas, USA, March 17-21, 2025. AB - Author manuscript AN - cdc:261923 C4 - PMC11871649 DO - https://doi.org/10.1016/j.antiviral.2024.106037 J2 - Antiviral Research KW - Antiviral Agents KW - Drug Discovery KW - Animals KW - Drug Development KW - COVID-19 Drug Treatment KW - Humans KW - COVID-19 KW - Vaccine Development KW - Animals KW - Humans KW - Antiviral Agents KW - COVID-19 KW - COVID-19 Drug Treatment KW - Drug Development KW - Drug Discovery KW - Vaccine Development LA - eng PY - 2024 T2 - Antiviral Research T2 - Antiviral Research, 2024, v. 232 TI - Meeting Report of the 37th International Conference on Antiviral Research in Gold Coast, Australia, May 20-24, 2024, Organized by the International Society For Antiviral Research. VL - 232 UR - https://stacks.cdc.gov/view/cdc/261923 ER -
Inequities in Hepatitis Virus Testing For Perinatally Exposed Infants in Tennessee: 2018 to 2023.

Thomas, Christine M. ;

Wingate, Heather

December 1, 2024 | Pediatrics, 2024, v. 154, no. 6

Approximately 6% to 7% of infants born to pregnant persons with hepatitis C virus (HCV) monoinfections acquire HCV infections. Although guidelines recommend testing infants who are perinatally exposed to HCV, only ~1 in 4 are tested. Curative HCV treatment is available for children aged ≥3 years. To guide HCV mitigation efforts in Tennessee, we exa ...

10/09/2026

Supporting Files

Title : Inequities in Hepatitis Virus Testing For Perinatally Exposed Infants in Tennessee: 2018 to 2023. Personal Author(s) : Thomas, Christine M.;Wingate, Heather;Roberts, Shamia;Sizemore, Lindsey;Fill, Mary-Margaret A.;Jones, Timothy F.;Schaffner, William;Dunn, John R.; Published Date : December 1, 2024 Pages in Document : 7 pdf pages Source : Pediatrics, 2024, v. 154, no. 6 DOI : https://doi.org/10.1542/peds.2024-067260 Journal Title : Pediatrics
Thomas, C. M., Wingate, H., Roberts, S., Sizemore, L., Fill, M. M. A., Jones, T. F., Schaffner, W., & Dunn, J. R. (2024). Inequities in Hepatitis Virus Testing For Perinatally Exposed Infants in Tennessee: 2018 to 2023. Pediatrics, 154(6). https://doi.org/10.1542/peds.2024-067260

Thomas, Christine M., Heather Wingate, Shamia Roberts, Lindsey Sizemore, Mary-Margaret A. Fill, Timothy F. Jones, William Schaffner, and John R. Dunn. "Inequities in Hepatitis Virus Testing For Perinatally Exposed Infants in Tennessee: 2018 to 2023." Pediatrics 154, no. 6 (2024). https://doi.org/10.1542/peds.2024-067260.

Thomas, Christine M., et al. "Inequities in Hepatitis Virus Testing For Perinatally Exposed Infants in Tennessee: 2018 to 2023." Pediatrics, vol. 154, no. 6, 2024. Stacks. https://doi.org/10.1542/peds.2024-067260.
Export RIS Citation Information. TY - Journal Article AU - Thomas, Christine M. AU - Wingate, Heather AU - Roberts, Shamia AU - Sizemore, Lindsey AU - Fill, Mary-Margaret A. AU - Jones, Timothy F. AU - Schaffner, William AU - Dunn, John R. AB - Approximately 6% to 7% of infants born to pregnant persons with hepatitis C virus (HCV) monoinfections acquire HCV infections. Although guidelines recommend testing infants who are perinatally exposed to HCV, only ~1 in 4 are tested. Curative HCV treatment is available for children aged ≥3 years. To guide HCV mitigation efforts in Tennessee, we examined the sociodemographic factors associated with HCV testing and infection among infants. AB - Author manuscript AN - cdc:261922 C4 - PMC11893069 DO - https://doi.org/10.1542/peds.2024-067260 IS - 6 J2 - Pediatrics KW - Pregnancy KW - Ethnicity KW - Female KW - Insurance KW - Infant KW - Hepatitis C KW - Birth Certificates KW - Perinatal Care KW - RNA KW - Hepatitis C KW - Perinatal Care KW - Infant KW - Female KW - Pregnancy KW - Birth Certificates KW - Ethnicity KW - Insurance KW - RNA LA - eng PY - 2024 T2 - Pediatrics T2 - Pediatrics, 2024, v. 154, no. 6 TI - Inequities in Hepatitis Virus Testing For Perinatally Exposed Infants in Tennessee: 2018 to 2023. VL - 154 UR - https://stacks.cdc.gov/view/cdc/261922 ER -
Trends in New Hepatitis C Virus Infections Among Repeat Blood Donors - Georgia, 2017-2023.

Shadaker, Shaun ;

Baliashvili, Davit

February 2025 | Transfusion Clinique Et Biologique: Journal de la Societe Francaise de Transfusion Sanguine, 2025, v. 32, no. 1

Blood donor cohorts are an underappreciated resource for surveillance and public health programming for infectious diseases. The incidence of hepatitis C virus (HCV) infection was evaluated in repeat blood donors in Georgia.Using data from the national hepatitis C screening registry, we calculated overall hepatitis C incidence for 2017-2023 and ann ...

10/09/2026

Supporting Files

Title : Trends in New Hepatitis C Virus Infections Among Repeat Blood Donors - Georgia, 2017-2023. Personal Author(s) : Shadaker, Shaun;Baliashvili, Davit;Alkhazashvili, Maia;Getia, Vladimer;Schumacher, Irina Tskhomelidze;Surguladze, Sophia;Handanagic, Senad;Tohme, Rania A;Bloch, Evan M; Published Date : February 2025 Pages in Document : 39-43 (12 pdf pages) Source : Transfusion Clinique Et Biologique: Journal de la Societe Francaise de Transfusion Sanguine, 2025, v. 32, no. 1 DOI : https://doi.org/10.1016/j.tracli.2024.11.004 Journal Title : Transfusion Clinique Et Biologique: Journal de la Societe Francaise de Transfusion Sanguine
Shadaker, S., Baliashvili, D., Alkhazashvili, M., Getia, V., Schumacher, I. T., Surguladze, S., Handanagic, S., Tohme, R. A., & Bloch, E. M. (2025). Trends in New Hepatitis C Virus Infections Among Repeat Blood Donors - Georgia, 2017-2023. Transfusion Clinique Et Biologique: Journal de la Societe Francaise de Transfusion Sanguine, 32(1). https://doi.org/10.1016/j.tracli.2024.11.004

Shadaker, Shaun, Davit Baliashvili, Maia Alkhazashvili, Vladimer Getia, Irina Tskhomelidze Schumacher, Sophia Surguladze, Senad Handanagic, Rania A Tohme, and Evan M Bloch. "Trends in New Hepatitis C Virus Infections Among Repeat Blood Donors - Georgia, 2017-2023." Transfusion Clinique Et Biologique: Journal de la Societe Francaise de Transfusion Sanguine 32, no. 1 (2025). https://doi.org/10.1016/j.tracli.2024.11.004.

Shadaker, Shaun, et al. "Trends in New Hepatitis C Virus Infections Among Repeat Blood Donors - Georgia, 2017-2023." Transfusion Clinique Et Biologique: Journal de la Societe Francaise de Transfusion Sanguine, vol. 32, no. 1, 2025. Stacks. https://doi.org/10.1016/j.tracli.2024.11.004.
Export RIS Citation Information. TY - Journal Article AU - Shadaker, Shaun AU - Baliashvili, Davit AU - Alkhazashvili, Maia AU - Getia, Vladimer AU - Schumacher, Irina Tskhomelidze AU - Surguladze, Sophia AU - Handanagic, Senad AU - Tohme, Rania A AU - Bloch, Evan M AB - Blood donor cohorts are an underappreciated resource for surveillance and public health programming for infectious diseases. The incidence of hepatitis C virus (HCV) infection was evaluated in repeat blood donors in Georgia. AB - Using data from the national hepatitis C screening registry, we calculated overall hepatitis C incidence for 2017-2023 and annual incidence during 2017-2022 among adults who donated blood at least twice and had a nonreactive HCV antibody (anti-HCV) test result upon first screening and a subsequent anti-HCV test conducted in any location. Rates of anti-HCV seroconversion and current infection were calculated by year, sex, age group, and location of last HCV screening and expressed per 100,000 person-years (PY). AB - Of 101,443 blood donors with ≥ 2 anti-HCV results,775 (0.8%) seroconverted to anti-HCV reactive, of whom 403 (52.0%) had current infection. Incidence of anti-HCV seroconversion decreased from 408 per 100,000 PY in 2017 to 218 per 100,000 PY in 2022 and incidence of infection decreased from 172 per 100,000 PY in 2017 to 118 per 100,000 PY in 2022. Males, persons aged 18-39 years, and people last tested for HCV in prisons had the highest incidence rates for anti-HCV seroconversion and HCV infection, while persons last screened in blood banks and during antenatal care had the lowest. AB - Despite the observed decline, incidence of HCV infection among repeat blood donors remains high in specific subgroups. Hepatitis C prevention, screening and treatment interventions need to particularly focus on incarcerated populations and young adults in Georgia. AB - Author manuscript AN - cdc:261921 C4 - PMC11867862 DO - https://doi.org/10.1016/j.tracli.2024.11.004 IS - 1 J2 - Transfusion Clinique Et Biologique: Journal de la Societe Francaise de Transfusion Sanguine KW - Adolescent KW - Female KW - Young Adult KW - Blood Donors KW - Hepatitis C KW - Incidence KW - Seroconversion KW - Male KW - Humans KW - Middle Aged KW - Hepatitis C Antibodies KW - Adult KW - Hepacivirus KW - Georgia (Republic) KW - Blood transfusion KW - Blood Donors KW - Hepatitis C KW - Epidemiology KW - Incidence KW - Georgia (Country) KW - Humans KW - Blood Donors KW - Male KW - Adult KW - Female KW - Hepatitis C KW - Adolescent KW - Young Adult KW - Georgia (Republic) KW - Incidence KW - Middle Aged KW - Hepatitis C Antibodies KW - Hepacivirus KW - Seroconversion LA - eng PY - 2025 T2 - Transfusion Clinique Et Biologique: Journal de la Societe Francaise de Transfusion Sanguine T2 - Transfusion Clinique Et Biologique: Journal de la Societe Francaise de Transfusion Sanguine, 2025, v. 32, no. 1 TI - Trends in New Hepatitis C Virus Infections Among Repeat Blood Donors - Georgia, 2017-2023. VL - 32 UR - https://stacks.cdc.gov/view/cdc/261921 ER -
Molecular Diagnosis of Onychomycosis: Outcomes From a Retrospective Study of 306 Patients at An Academic Center in New York City.

Katsiaunis, Apostolos ;

Bakotic, Wayne

March 2025 | Journal of the American Academy of Dermatology, 2025, v. 92, no. 3

Letter to the editor regarding Onychomycosis and using polymerase chain reaction to identify the causative pathogen.

10/09/2026

Supporting Files

Title : Molecular Diagnosis of Onychomycosis: Outcomes From a Retrospective Study of 306 Patients at An Academic Center in New York City. Personal Author(s) : Katsiaunis, Apostolos;Bakotic, Wayne;Gold, Jeremy A. W.;Lipner, Shari R.; Published Date : March 2025 Pages in Document : 623-625 (5 pdf pages) Source : Journal of the American Academy of Dermatology, 2025, v. 92, no. 3 DOI : https://doi.org/10.1016/j.jaad.2024.11.008 Journal Title : Journal of the American Academy of Dermatology
Katsiaunis, A., Bakotic, W., Gold, J. A. W., & Lipner, S. R. (2025). Molecular Diagnosis of Onychomycosis: Outcomes From a Retrospective Study of 306 Patients at An Academic Center in New York City. Journal of the American Academy of Dermatology, 92(3). https://doi.org/10.1016/j.jaad.2024.11.008

Katsiaunis, Apostolos, Wayne Bakotic, Jeremy A. W. Gold, and Shari R. Lipner. "Molecular Diagnosis of Onychomycosis: Outcomes From a Retrospective Study of 306 Patients at An Academic Center in New York City." Journal of the American Academy of Dermatology 92, no. 3 (2025). https://doi.org/10.1016/j.jaad.2024.11.008.

Katsiaunis, Apostolos, et al. "Molecular Diagnosis of Onychomycosis: Outcomes From a Retrospective Study of 306 Patients at An Academic Center in New York City." Journal of the American Academy of Dermatology, vol. 92, no. 3, 2025. Stacks. https://doi.org/10.1016/j.jaad.2024.11.008.
Export RIS Citation Information. TY - Journal Article AU - Katsiaunis, Apostolos AU - Bakotic, Wayne AU - Gold, Jeremy A. W. AU - Lipner, Shari R. AB - Letter to the editor regarding Onychomycosis and using polymerase chain reaction to identify the causative pathogen. AB - Author manuscript AN - cdc:261920 C4 - PMC11859757 DO - https://doi.org/10.1016/j.jaad.2024.11.008 IS - 3 J2 - Journal of the American Academy of Dermatology KW - Onychomycosis KW - culture KW - dermatophyte KW - nail disorder KW - nails KW - onychomycosis KW - polymerase chain reaction KW - Onychomycosis LA - eng PY - 2025 T2 - Journal of the American Academy of Dermatology T2 - Journal of the American Academy of Dermatology, 2025, v. 92, no. 3 TI - Molecular Diagnosis of Onychomycosis: Outcomes From a Retrospective Study of 306 Patients at An Academic Center in New York City. VL - 92 UR - https://stacks.cdc.gov/view/cdc/261920 ER -
Association of Cognitive and Structural Correlates of Brain Aging and Incident Epilepsy. the Framingham Heart Study.

Stefanidou, Maria ;

Himali, Jayandra J.

January 2025 | Epilepsia, 2025, v. 66, no. 1

Late-onset epilepsy has the highest incidence among all age groups affected by epilepsy and often occurs in the absence of known clinical risk factors such as stroke and dementia. There is increasing evidence that brain changes contributing to epileptogenesis likely start years before disease onset, and we aim to relate cognitive and imaging correl ...

10/09/2026

Supporting Files

Title : Association of Cognitive and Structural Correlates of Brain Aging and Incident Epilepsy. the Framingham Heart Study. Personal Author(s) : Stefanidou, Maria;Himali, Jayandra J.;Bernal, Rebecca;Satizabal, Claudia;Devinsky, Orrin;Romero, Jose R.;Beiser, Alexa S.;Seshadri, Sudha;Friedman, Daniel; Published Date : January 2025 Pages in Document : 160-169 (17 pdf pages) Source : Epilepsia, 2025, v. 66, no. 1 DOI : https://doi.org/10.1111/epi.18160 Journal Title : Epilepsia
Stefanidou, M., Himali, J. J., Bernal, R., Satizabal, C., Devinsky, O., Romero, J. R., Beiser, A. S., Seshadri, S., & Friedman, D. (2025). Association of Cognitive and Structural Correlates of Brain Aging and Incident Epilepsy. the Framingham Heart Study. Epilepsia, 66(1). https://doi.org/10.1111/epi.18160

Stefanidou, Maria, Jayandra J. Himali, Rebecca Bernal, Claudia Satizabal, Orrin Devinsky, Jose R. Romero, Alexa S. Beiser, Sudha Seshadri, and Daniel Friedman. "Association of Cognitive and Structural Correlates of Brain Aging and Incident Epilepsy. the Framingham Heart Study." Epilepsia 66, no. 1 (2025). https://doi.org/10.1111/epi.18160.

Stefanidou, Maria, et al. "Association of Cognitive and Structural Correlates of Brain Aging and Incident Epilepsy. the Framingham Heart Study." Epilepsia, vol. 66, no. 1, 2025. Stacks. https://doi.org/10.1111/epi.18160.
Export RIS Citation Information. TY - Journal Article AU - Stefanidou, Maria AU - Himali, Jayandra J. AU - Bernal, Rebecca AU - Satizabal, Claudia AU - Devinsky, Orrin AU - Romero, Jose R. AU - Beiser, Alexa S. AU - Seshadri, Sudha AU - Friedman, Daniel AB - Late-onset epilepsy has the highest incidence among all age groups affected by epilepsy and often occurs in the absence of known clinical risk factors such as stroke and dementia. There is increasing evidence that brain changes contributing to epileptogenesis likely start years before disease onset, and we aim to relate cognitive and imaging correlates of subclinical brain injury to incident late-onset epilepsy in a large, community-based cohort. AB - We studied Offspring Cohort of the Framingham Heart Study participants 45 years or older, who were free of prevalent stroke, dementia, or epilepsy, and had neuropsychological (NP) evaluation and brain magnetic resonance imaging (MRI). Cognitive measures included Visual Reproduction Delayed Recall, Logical Memory Delayed Recall, Similarities, Trail Making Test B minus A (TrTB-TrTA; attention and executive function), and a global measure of cognition derived from principal component analysis. MRI measures included total cerebral brain volume, cortical gray matter volume (CGMV), white matter hyperintensity volume (WMHV), and hippocampal volume. Incident epilepsy was identified through a review of administrative data and medical records. Cox proportional hazards regression models were used for the analyses. All analyses were adjusted for age, sex, and educational level (cognition only). AB - Among participants who underwent NP testing (n = 2349, 45.81% male), 31 incident epilepsy cases were identified during follow-up. Better performance on the TrTB-TrTA was associated with a lower risk of developing epilepsy (hazard ratio [HR] .25, 95% confidence interval [CI] .08-.73; p = .011). In the subgroup of participants with MRI (n = 2056, 46.01% male), 27 developed epilepsy. Higher WMHV was associated with higher epilepsy risk (HR 1.5, 95%CI 1.01-2.20; p = .042), but higher CGMV (HR .73, 95% CI .57-.93; p = .001) was associated with lower incidence of epilepsy. AB - Better performance on the (TrTB-TrTA), a measure of executive function and attention, and higher cortical volumes are associated with lower risk of developing epilepsy. Conversely, higher WMHV, a measure of occult vascular injury, increases the risk. Our study shows that non-invasive tests performed in mid-life may help identify people at risk for developing epilepsy later in life. AB - Author manuscript AN - cdc:261919 C4 - PMC11875459 DO - https://doi.org/10.1111/epi.18160 IS - 1 J2 - Epilepsia KW - Female KW - Aged KW - Cognition KW - Neuropsychological Tests KW - Aging KW - Magnetic Resonance Imaging KW - Cohort Studies KW - Brain KW - Epilepsy KW - Incidence KW - Male KW - Middle Aged KW - Humans KW - epilepsy KW - elderly KW - neuroepidemiology KW - cognitive testing KW - MRI brain KW - Humans KW - Male KW - Female KW - Epilepsy KW - Magnetic Resonance Imaging KW - Brain KW - Middle Aged KW - Aged KW - Aging KW - Neuropsychological Tests KW - Incidence KW - Cohort Studies KW - Cognition LA - eng PY - 2025 T2 - Epilepsia T2 - Epilepsia, 2025, v. 66, no. 1 TI - Association of Cognitive and Structural Correlates of Brain Aging and Incident Epilepsy. the Framingham Heart Study. VL - 66 UR - https://stacks.cdc.gov/view/cdc/261919 ER -
JYNNEOS Vaccine Safety Surveillance in the Vaccine Safety Datalink During the 2022 Mpox Outbreak in the United States.

Duffy, Jonathan ;

Yih, W. Katherine

August 2025 | Infection, 2025, v. 53, no. 4

The JYNNEOS vaccine (two doses given 28 days apart) was recommended in the United States for people at high risk of exposure to monkeypox virus during the 2022 mpox outbreak. Our objective was to assess the safety of JYNNEOS using two complementary epidemiologic methods.This observational cohort included patients of eight large integrated healthcar ...

10/09/2026

Supporting Files

Title : JYNNEOS Vaccine Safety Surveillance in the Vaccine Safety Datalink During the 2022 Mpox Outbreak in the United States. Personal Author(s) : Duffy, Jonathan;Yih, W. Katherine;Walton, Kimp;DeSilva, Malini B.;Glanz, Jason M.;Hambidge, Simon J;Jackson, Lisa A.;Klein, Nicola P.;Lewin, Bruno J.;Naleway, Allison L.;Sundaram, Maria E.;Maro, Judith C.;Weintraub, Eric; Published Date : August 2025 Pages in Document : 1321-1328 (14 pdf pages) Source : Infection, 2025, v. 53, no. 4 DOI : https://doi.org/10.1007/s15010-024-02428-1 Journal Title : Infection
Duffy, J., Yih, W. K., Walton, K., DeSilva, M. B., Glanz, J. M., Hambidge, S. J., Jackson, L. A., Klein, N. P., Lewin, B. J., Naleway, A. L., Sundaram, M. E., Maro, J. C., & Weintraub, E. (2025). JYNNEOS Vaccine Safety Surveillance in the Vaccine Safety Datalink During the 2022 Mpox Outbreak in the United States. Infection, 53(4). https://doi.org/10.1007/s15010-024-02428-1

Duffy, Jonathan, W. Katherine Yih, Kimp Walton, Malini B. DeSilva, Jason M. Glanz, Simon J Hambidge, and Lisa A. Jackson, et al.. "JYNNEOS Vaccine Safety Surveillance in the Vaccine Safety Datalink During the 2022 Mpox Outbreak in the United States." Infection 53, no. 4 (2025). https://doi.org/10.1007/s15010-024-02428-1.

Duffy, Jonathan, et al. "JYNNEOS Vaccine Safety Surveillance in the Vaccine Safety Datalink During the 2022 Mpox Outbreak in the United States." Infection, vol. 53, no. 4, 2025. Stacks. https://doi.org/10.1007/s15010-024-02428-1.
Export RIS Citation Information. TY - Journal Article AU - Duffy, Jonathan AU - Yih, W. Katherine AU - Walton, Kimp AU - DeSilva, Malini B. AU - Glanz, Jason M. AU - Hambidge, Simon J AU - Jackson, Lisa A. AU - Klein, Nicola P. AU - Lewin, Bruno J. AU - Naleway, Allison L. AU - Sundaram, Maria E. AU - Maro, Judith C. AU - Weintraub, Eric AB - The JYNNEOS vaccine (two doses given 28 days apart) was recommended in the United States for people at high risk of exposure to monkeypox virus during the 2022 mpox outbreak. Our objective was to assess the safety of JYNNEOS using two complementary epidemiologic methods. AB - This observational cohort included patients of eight large integrated healthcare organizations who received JYNNEOS. Adverse events were identified using ICD-10 coded diagnoses assigned to medical visits. The first analysis used standardized incidence ratios (SIR) to compare the observed incidence of ten prespecified adverse events of special interest (AESI) during the 28 days after receipt of each dose of JYNNEOS to the expected incidence adjusted for several risk factors. The second analysis used tree-based data mining to identify temporal clustering of cases for more than 60,000 diagnoses and diagnosis groups within 70-days after JYNNEOS dose 1 administration. AB - The SIR analysis included 53,583 adults who received JYNNEOS dose 1 and 38,206 who received dose 2. Males received 92% of the doses. There were no statistically significant elevated SIRs for any of the ten AESI. The tree-based data mining analysis included 36,912 vaccinees. Analysis of diagnoses in inpatient, emergency department, and outpatient settings identified statistically significant clusters of visits for rash and unspecified adverse effects. AB - No new or unexpected safety concerns were identified. AESI did not occur more frequently than expected by chance alone. Non-serious medically attended adverse events, such as rash, have been previously reported and occurred infrequently. AB - Author manuscript AN - cdc:261918 C4 - PMC12089422 DO - https://doi.org/10.1007/s15010-024-02428-1 IS - 4 J2 - Infection KW - Adolescent KW - Cohort Studies KW - Female KW - Incidence KW - Male KW - Aged KW - Disease Outbreaks KW - Humans KW - Middle Aged KW - Young Adult KW - Mpox, Monkeypox KW - Adult KW - mpox KW - smallpox vaccine KW - vaccine safety KW - adverse event KW - myocarditis KW - Humans KW - Male KW - Female KW - Adult KW - Middle Aged KW - Disease Outbreaks KW - Mpox, Monkeypox KW - Aged KW - Young Adult KW - Adolescent KW - Incidence KW - Cohort Studies LA - eng PY - 2025 T2 - Infection T2 - Infection, 2025, v. 53, no. 4 TI - JYNNEOS Vaccine Safety Surveillance in the Vaccine Safety Datalink During the 2022 Mpox Outbreak in the United States. VL - 53 UR - https://stacks.cdc.gov/view/cdc/261918 ER -
Correspondence to Escape Velocity-The Launch of Microbiome Therapies .

Olle, Bernat ;

Ranallo, Ryan

February 20, 2025 | The Journal of Infectious Diseases, 2025, v. 231, no. 2

Letter to the editor in response to Kelly BJ, Kwon JH, Woodworth MH. Escape Velocity-the Launch of Microbiome Therapies. J Infect Dis. 2024 Jul 25;230(1):2-4. doi: 10.1093/infdis/jiae099. PMID: 39052747; PMCID: PMC11272035. This letter clarifies terminology regarding live biotheraputic products.

10/09/2026

Supporting Files

Title : Correspondence to Escape Velocity-The Launch of Microbiome Therapies . Personal Author(s) : Olle, Bernat;Ranallo, Ryan;McDonald, L. Clifford; Published Date : February 20, 2025 Pages in Document : 544 (2 pdf pages) Source : The Journal of Infectious Diseases, 2025, v. 231, no. 2 DOI : https://doi.org/10.1093/infdis/jiae575 Journal Title : The Journal of Infectious Diseases
Olle, B., Ranallo, R., & McDonald, L. C. (2025). Correspondence to Escape Velocity-The Launch of Microbiome Therapies. The Journal of Infectious Diseases, 231(2). https://doi.org/10.1093/infdis/jiae575

Olle, Bernat, Ryan Ranallo, and L. Clifford McDonald. "Correspondence to Escape Velocity-The Launch of Microbiome Therapies." The Journal of Infectious Diseases 231, no. 2 (2025). https://doi.org/10.1093/infdis/jiae575.

Olle, Bernat, et al. "Correspondence to Escape Velocity-The Launch of Microbiome Therapies." The Journal of Infectious Diseases, vol. 231, no. 2, 2025. Stacks. https://doi.org/10.1093/infdis/jiae575.
Export RIS Citation Information. TY - Journal Article AU - Olle, Bernat AU - Ranallo, Ryan AU - McDonald, L. Clifford AB - Letter to the editor in response to Kelly BJ, Kwon JH, Woodworth MH. Escape Velocity-the Launch of Microbiome Therapies. J Infect Dis. 2024 Jul 25;230(1):2-4. doi: 10.1093/infdis/jiae099. PMID: 39052747; PMCID: PMC11272035. This letter clarifies terminology regarding live biotheraputic products. AB - Author manuscript AN - cdc:261917 C4 - PMC12486162 DO - https://doi.org/10.1093/infdis/jiae575 IS - 2 J2 - The Journal of Infectious Diseases KW - Clostridioides difficile KW - Fecal Microbiota Transplantation KW - Translational Research, Biomedical KW - Microbiota KW - Humans KW - Humans KW - Clostridioides difficile KW - Fecal Microbiota Transplantation KW - Translational Research, Biomedical KW - Microbiota LA - eng PY - 2025 T2 - The Journal of Infectious Diseases T2 - The Journal of Infectious Diseases, 2025, v. 231, no. 2 TI - Correspondence to Escape Velocity-The Launch of Microbiome Therapies . VL - 231 UR - https://stacks.cdc.gov/view/cdc/261917 ER -
Child and Family Characteristics Associated With Verbal Communication Difficulties in Adolescents With Autism and Other Developmental Disabilities.

Powell, Patrick S. ;

Gonzalez, Maria G.

December 2024 | Research in Developmental Disabilities, 2024, v. 155

Verbal communication difficulties are associated with a range of adolescent and adult outcomes in individuals with autism spectrum disorder (ASD). Yet there is limited information about contextual factors associated with verbal communication difficulties beyond early childhood, and how youth with ASD compare to youth with other developmental disabi ...

10/09/2026

Supporting Files

Title : Child and Family Characteristics Associated With Verbal Communication Difficulties in Adolescents With Autism and Other Developmental Disabilities. Personal Author(s) : Powell, Patrick S.;Gonzalez, Maria G.;Pazol, Karen;Reyes, Nuri;Nadler, Cy;Wiggins, Lisa; Published Date : December 2024 Pages in Document : 104879 (20 pdf pages) Source : Research in Developmental Disabilities, 2024, v. 155 DOI : https://doi.org/10.1016/j.ridd.2024.104879 Journal Title : Research in Developmental Disabilities
Powell, P. S., Gonzalez, M. G., Pazol, K., Reyes, N., Nadler, C., & Wiggins, L. (2024). Child and Family Characteristics Associated With Verbal Communication Difficulties in Adolescents With Autism and Other Developmental Disabilities. Research in Developmental Disabilities, 155. https://doi.org/10.1016/j.ridd.2024.104879

Powell, Patrick S., Maria G. Gonzalez, Karen Pazol, Nuri Reyes, Cy Nadler, and Lisa Wiggins. "Child and Family Characteristics Associated With Verbal Communication Difficulties in Adolescents With Autism and Other Developmental Disabilities." Research in Developmental Disabilities 155 (2024). https://doi.org/10.1016/j.ridd.2024.104879.

Powell, Patrick S., et al. "Child and Family Characteristics Associated With Verbal Communication Difficulties in Adolescents With Autism and Other Developmental Disabilities." Research in Developmental Disabilities, vol. 155, 2024. Stacks. https://doi.org/10.1016/j.ridd.2024.104879.
Export RIS Citation Information. TY - Journal Article AU - Powell, Patrick S. AU - Gonzalez, Maria G. AU - Pazol, Karen AU - Reyes, Nuri AU - Nadler, Cy AU - Wiggins, Lisa AB - Verbal communication difficulties are associated with a range of adolescent and adult outcomes in individuals with autism spectrum disorder (ASD). Yet there is limited information about contextual factors associated with verbal communication difficulties beyond early childhood, and how youth with ASD compare to youth with other developmental disabilities (DD). AB - The current study examined verbal communication difficulties among adolescents with ASD and other DD, and child and family characteristics associated with these difficulties in later in life. AB - Children were classified as ASD or other DD between 2 and 5 years old. Caregivers of these same children reported verbal communication difficulties between 12 and 16 years old. Chi square tests examined group differences in adolescent verbal communication difficulties; Poisson regression examined child and family characteristics associated with adolescent verbal communication difficulties. AB - Adolescents with ASD had significantly more verbal communication difficulties (47.4 %) than adolescents with other DD (14.6 %). Factors that predicted verbal communication difficulties in adolescents with ASD and other DD were expressive language abilities and internalizing symptoms in early childhood, having a mother of non-Hispanic Black compared to White race, and having a mother with some college compared to an advanced degree. AB - Almost half of adolescents with ASD had verbal communication difficulties, which was significantly higher than those with other DD. Early childhood and socio-demographic factors like race, education, and insurance were associated with verbal language outcomes. These factors may be useful in identifying and supporting those most likely to benefit from targeted communication services. WHAT THIS PAPER ADDS?: Verbal communication difficulties are common among adolescents with autism. Early childhood and socio-demographic characteristics like race and education are associated with these difficulties. These findings could help better identify and support adolescents with communication difficulties. AB - Author manuscript AN - cdc:261916 C4 - PMC11881030 DO - https://doi.org/10.1016/j.ridd.2024.104879 J2 - Research in Developmental Disabilities KW - Adolescent KW - White KW - Female KW - Family Characteristics KW - Language Development Disorders KW - Verbal Behavior KW - Mothers KW - Child KW - Communication KW - Autism Spectrum Disorder KW - Male KW - Educational Status KW - Humans KW - Black or African American KW - Child, Preschool KW - Developmental Disabilities KW - Communication Disorders KW - Autism KW - Communication KW - Language KW - Adolescence KW - Verbal KW - Adolescent KW - Child KW - Child, Preschool KW - Female KW - Humans KW - Male KW - Autism Spectrum Disorder KW - Black or African American KW - Communication KW - Communication Disorders KW - Developmental Disabilities KW - Educational Status KW - Family Characteristics KW - Language Development Disorders KW - Mothers KW - Verbal Behavior KW - White LA - eng PY - 2024 T2 - Research in Developmental Disabilities T2 - Research in Developmental Disabilities, 2024, v. 155 TI - Child and Family Characteristics Associated With Verbal Communication Difficulties in Adolescents With Autism and Other Developmental Disabilities. VL - 155 UR - https://stacks.cdc.gov/view/cdc/261916 ER -
Assessing Prenatal Alcohol Exposure History For Pediatric Patients: Practices Among U.S. Clinicians.

Dunkley, Janae ;

Deputy, Nicholas P.

April 2025 | Maternal and Child Health Journal, 2025, v. 29, no. 4

The American Academy of Pediatrics recommends clinicians who treat pediatric patients screen for prenatal alcohol exposure (PAE) to facilitate the identification of children with fetal alcohol spectrum disorders and promote timely access to behavioral and cognitive interventions. We evaluated how frequently clinicians inquire about PAE in their ped ...

10/09/2026

Supporting Files

Title : Assessing Prenatal Alcohol Exposure History For Pediatric Patients: Practices Among U.S. Clinicians. Personal Author(s) : Dunkley, Janae;Deputy, Nicholas P.;Denny, Clark H.;Bertrand, Jacquelyn;Godfred-Cato, Shana;Kim, Shin Y.; Published Date : April 2025 Pages in Document : 449-456 (14 pdf pages) Source : Maternal and Child Health Journal, 2025, v. 29, no. 4 DOI : https://doi.org/10.1007/s10995-024-04015-0 Journal Title : Maternal and Child Health Journal
Dunkley, J., Deputy, N. P., Denny, C. H., Bertrand, J., Godfred-Cato, S., & Kim, S. Y. (2025). Assessing Prenatal Alcohol Exposure History For Pediatric Patients: Practices Among U.S. Clinicians. Maternal and Child Health Journal, 29(4). https://doi.org/10.1007/s10995-024-04015-0

Dunkley, Janae, Nicholas P. Deputy, Clark H. Denny, Jacquelyn Bertrand, Shana Godfred-Cato, and Shin Y. Kim. "Assessing Prenatal Alcohol Exposure History For Pediatric Patients: Practices Among U.S. Clinicians." Maternal and Child Health Journal 29, no. 4 (2025). https://doi.org/10.1007/s10995-024-04015-0.

Dunkley, Janae, et al. "Assessing Prenatal Alcohol Exposure History For Pediatric Patients: Practices Among U.S. Clinicians." Maternal and Child Health Journal, vol. 29, no. 4, 2025. Stacks. https://doi.org/10.1007/s10995-024-04015-0.
Export RIS Citation Information. TY - Journal Article AU - Dunkley, Janae AU - Deputy, Nicholas P. AU - Denny, Clark H. AU - Bertrand, Jacquelyn AU - Godfred-Cato, Shana AU - Kim, Shin Y. AB - The American Academy of Pediatrics recommends clinicians who treat pediatric patients screen for prenatal alcohol exposure (PAE) to facilitate the identification of children with fetal alcohol spectrum disorders and promote timely access to behavioral and cognitive interventions. We evaluated how frequently clinicians inquire about PAE in their pediatric patient interactions and the methods used to ascertain this information. AB - We analyzed data from the Fall 2020 DocStyles survey, a web-based survey of primary healthcare professionals (n = 1754). Distributions for frequency of assessing PAE history for five pediatric populations and the methods used were calculated by clinician specialty (family practitioners [FP], pediatricians, and nurse practitioners/physician assistants [NP/PAs]) and overall. Chi-square and Bonferroni post-hoc tests determined whether frequency of assessing PAE history varied by specialty. AB - Among 779 clinicians serving pediatric patients, approximately 70.5%, 63.0%, and 60.7% reported often/always obtaining PAE history from parents of children with developmental/behavioral issues, adopted/foster children, and newborns, respectively. By contrast, less than half of respondents reported often/always collecting this information from parents of infants (47.6%) and new patients (38.2%). Most respondents reported collecting PAE history through interviews conducted by physicians or physician assistants (69.7%). Obtaining PAE history varied by specialty; pediatricians (71.5%) were more likely to collect PAE history for adopted/foster children when compared to FPs (57.7%, p = 0.003). AB - PAE history is not routinely obtained for pediatric patients. These findings highlight the need for trainings and practice supports to aid clinicians in identifying and treating children at-risk of FASDs. AB - Author manuscript AN - cdc:261915 C4 - PMC12005974 DO - https://doi.org/10.1007/s10995-024-04015-0 IS - 4 J2 - Maternal and Child Health Journal KW - Pregnancy KW - Child KW - Medical History Taking KW - Female KW - Surveys and Questionnaires KW - Fetal Alcohol Spectrum Disorders KW - Pediatrics KW - Prenatal Exposure Delayed Effects KW - Male KW - Humans KW - Adult KW - Practice Patterns, Physicians' KW - Developmental disabilities KW - Developmental/behavioral issues KW - Fetal alcohol syndrome KW - Fetal alcohol spectrum disorders KW - Prenatal alcohol exposure KW - Humans KW - Female KW - Fetal Alcohol Spectrum Disorders KW - Pregnancy KW - Surveys and Questionnaires KW - Male KW - Adult KW - Prenatal Exposure Delayed Effects KW - Practice Patterns, Physicians' KW - Child KW - Medical History Taking KW - Pediatrics LA - eng PY - 2025 T2 - Maternal and Child Health Journal T2 - Maternal and Child Health Journal, 2025, v. 29, no. 4 TI - Assessing Prenatal Alcohol Exposure History For Pediatric Patients: Practices Among U.S. Clinicians. VL - 29 UR - https://stacks.cdc.gov/view/cdc/261915 ER -
Epidemiology and Response to the COVID-19 Pandemic in the Dadaab Refugee Camp Complex, Kenya, March 2020-December 2022.

Ope, Maurice ;

Musyoka, Raymond

April 4, 2025 | Travel Medicine and Infectious Disease, 2025, v. 63

Refugee settings may increase the risk of SARS-CoV-2 infection and death, yet data on the response to the pandemic in these populations is scarce.We describe interventions to mitigate SARS-CoV-2 transmission in Dadaab Refugee Camp Complex, Kenya and performed descriptive analyses using March 2020 to December 2022 data from Kenya's national SARS-CoV ...

10/09/2026

Supporting Files

Title : Epidemiology and Response to the COVID-19 Pandemic in the Dadaab Refugee Camp Complex, Kenya, March 2020-December 2022. Personal Author(s) : Ope, Maurice;Musyoka, Raymond;Kosar, Abdihakim;Osman, Mohammed;Hassan, Abdijamal;Mohammed, Hussein;Munyua, Penina;Juma, Bonventure;Hunsperger, Elizabeth;Mohammed, Sofia;Burton, John;Eidex, Rachel B.; Published Date : April 4, 2025 Pages in Document : 102785 (14 pdf pages) Source : Travel Medicine and Infectious Disease, 2025, v. 63 DOI : https://doi.org/10.1016/j.tmaid.2024.102785 Journal Title : Travel Medicine and Infectious Disease
Ope, M., Musyoka, R., Kosar, A., Osman, M., Hassan, A., Mohammed, H., Munyua, P., Juma, B., Hunsperger, E., Mohammed, S., Burton, J., & Eidex, R. B. (2025). Epidemiology and Response to the COVID-19 Pandemic in the Dadaab Refugee Camp Complex, Kenya, March 2020-December 2022. Travel Medicine and Infectious Disease, 63. https://doi.org/10.1016/j.tmaid.2024.102785

Ope, Maurice, Raymond Musyoka, Abdihakim Kosar, Mohammed Osman, Abdijamal Hassan, Hussein Mohammed, and Penina Munyua, et al.. "Epidemiology and Response to the COVID-19 Pandemic in the Dadaab Refugee Camp Complex, Kenya, March 2020-December 2022." Travel Medicine and Infectious Disease 63 (2025). https://doi.org/10.1016/j.tmaid.2024.102785.

Ope, Maurice, et al. "Epidemiology and Response to the COVID-19 Pandemic in the Dadaab Refugee Camp Complex, Kenya, March 2020-December 2022." Travel Medicine and Infectious Disease, vol. 63, 2025. Stacks. https://doi.org/10.1016/j.tmaid.2024.102785.
Export RIS Citation Information. TY - Journal Article AU - Ope, Maurice AU - Musyoka, Raymond AU - Kosar, Abdihakim AU - Osman, Mohammed AU - Hassan, Abdijamal AU - Mohammed, Hussein AU - Munyua, Penina AU - Juma, Bonventure AU - Hunsperger, Elizabeth AU - Mohammed, Sofia AU - Burton, John AU - Eidex, Rachel B. AB - Refugee settings may increase the risk of SARS-CoV-2 infection and death, yet data on the response to the pandemic in these populations is scarce. AB - We describe interventions to mitigate SARS-CoV-2 transmission in Dadaab Refugee Camp Complex, Kenya and performed descriptive analyses using March 2020 to December 2022 data from Kenya's national SARS-CoV-2 repository and line list of positive cases maintained by United Nations High Commissioner for Refugees (UNHCR). We calculated case fatality rates (CFR) and attack rates per 100,000 (AR) using the 2019 national census and population statistics from UNHCR and compared them to national figures. AB - SARS-CoV-2 infection was first reported in April and May 2020, among host community members and refugees respectively. Of 964 laboratory-confirmed cases, 700 (72.6 %) were refugees. The AR was 82.7 (95 % CI 72.6-92.8) for host community members, 228.3 (95 % CI 211.3-245.4) for refugees and 721.1 (95 % CI 718.7-723.5) nationally. The CFR was 1.5 % (95 % CI 0.15-3.18) for host community members, 1.76 % (95 % CI 1.71-1.80) nationally and 7.4 % (95 % CI 5.4-9.4) for refugees. Mitigation measures implemented by the Government of Kenya, UNHCR and partners during the pandemic included multisectoral coordination, movement restrictions, mass gathering bans, and health promotion. Social distancing, symptom screening and mandatory mask usage were enforced during mass gatherings. Testing capacity was bolstered, quarantine and isolation facilities established, and vaccination initiated. AB - Despite a low AR and UNHCR's swift and comprehensive response, refugees' CFR was high, underscoring their vulnerability and need for targeted interventions during epidemic responses. AB - Author manuscript AN - cdc:261914 C4 - PMC11968409 DO - https://doi.org/10.1016/j.tmaid.2024.102785 J2 - Travel Medicine and Infectious Disease KW - Adolescent KW - Female KW - Pandemics KW - SARS-CoV-2 KW - Aged KW - Young Adult KW - COVID-19 KW - Refugees KW - Child KW - Refugee Camps KW - Infant KW - Male KW - Middle Aged KW - Humans KW - Child, Preschool KW - Adult KW - Refugees KW - Epidemiology KW - SARS-CoV-2 KW - COVID-19 KW - pandemic response KW - Humans KW - COVID-19 KW - Refugee Camps KW - Refugees KW - SARS-CoV-2 KW - Male KW - Adult KW - Female KW - Adolescent KW - Young Adult KW - Child KW - Middle Aged KW - Child, Preschool KW - Pandemics KW - Infant KW - Aged LA - eng PY - 2025 T2 - Travel Medicine and Infectious Disease T2 - Travel Medicine and Infectious Disease, 2025, v. 63 TI - Epidemiology and Response to the COVID-19 Pandemic in the Dadaab Refugee Camp Complex, Kenya, March 2020-December 2022. VL - 63 UR - https://stacks.cdc.gov/view/cdc/261914 ER -
Demographic Characteristics and County-level Indicators of Social Vulnerability in Salmonellosis Outbreaks Linked to Ground Beef-United States, 2012-2018.

Waltenburg, Michelle A. ;

Salah, Zainab

January 2025 | Journal of Food Protection, 2025, v. 88, no. 1

Ground beef is a common source of US Salmonella illnesses and outbreaks. However, the demographic and socioeconomic factors that are related to risk in ground beef-associated outbreaks of Salmonella infections are poorly understood. We describe the individual-level demographic characteristics and county-level indicators of social vulnerability for ...

10/09/2026

Supporting Files

Title : Demographic Characteristics and County-level Indicators of Social Vulnerability in Salmonellosis Outbreaks Linked to Ground Beef-United States, 2012-2018. Personal Author(s) : Waltenburg, Michelle A.;Salah, Zainab;Canning, Michelle;McCain, Kelly;Rickless, David;Ablan, Michael;Crawford, Tamara N.;Low, Mabel Sheau Fong;Robyn, Misha;Molinari, Noelle Angelique M.;Marshall, Katherine E.; Published Date : January 2025 Pages in Document : 100411 (22 pdf pages) Source : Journal of Food Protection, 2025, v. 88, no. 1 DOI : https://doi.org/10.1016/j.jfp.2024.100411 Journal Title : Journal of Food Protection
Waltenburg, M. A., Salah, Z., Canning, M., McCain, K., Rickless, D., Ablan, M., Crawford, T. N., Low, M. S. F., Robyn, M., Molinari, N. A. M., & Marshall, K. E. (2025). Demographic Characteristics and County-level Indicators of Social Vulnerability in Salmonellosis Outbreaks Linked to Ground Beef-United States, 2012-2018. Journal of Food Protection, 88(1). https://doi.org/10.1016/j.jfp.2024.100411

Waltenburg, Michelle A., Zainab Salah, Michelle Canning, Kelly McCain, David Rickless, Michael Ablan, and Tamara N. Crawford, et al.. "Demographic Characteristics and County-level Indicators of Social Vulnerability in Salmonellosis Outbreaks Linked to Ground Beef-United States, 2012-2018." Journal of Food Protection 88, no. 1 (2025). https://doi.org/10.1016/j.jfp.2024.100411.

Waltenburg, Michelle A., et al. "Demographic Characteristics and County-level Indicators of Social Vulnerability in Salmonellosis Outbreaks Linked to Ground Beef-United States, 2012-2018." Journal of Food Protection, vol. 88, no. 1, 2025. Stacks. https://doi.org/10.1016/j.jfp.2024.100411.
Export RIS Citation Information. TY - Journal Article AU - Waltenburg, Michelle A. AU - Salah, Zainab AU - Canning, Michelle AU - McCain, Kelly AU - Rickless, David AU - Ablan, Michael AU - Crawford, Tamara N. AU - Low, Mabel Sheau Fong AU - Robyn, Misha AU - Molinari, Noelle Angelique M. AU - Marshall, Katherine E. AB - Ground beef is a common source of US Salmonella illnesses and outbreaks. However, the demographic and socioeconomic factors that are related to risk in ground beef-associated outbreaks of Salmonella infections are poorly understood. We describe the individual-level demographic characteristics and county-level indicators of social vulnerability for people infected with Salmonella linked to outbreaks associated with ground beef in the United States during 2012-2018. Non-Hispanic (NH) White and NH American Indian/Alaska Native persons, and people living in nonmetropolitan areas, were overrepresented among people in salmonellosis outbreaks linked to ground beef. Case patients disproportionately resided in counties with high social vulnerability, suggesting that one or more community social risk factors may contribute to or be associated with some food safety risks. Collecting and analyzing socioeconomic and demographic characteristics of people in outbreaks can help identify disparities in foodborne disease, which can be further characterized and inform equity-focused interventions. AB - Author manuscript AN - cdc:261913 C4 - PMC11773426 DO - https://doi.org/10.1016/j.jfp.2024.100411 IS - 1 J2 - Journal of Food Protection KW - Adolescent KW - Salmonella Infections KW - Female KW - Animals KW - Aged KW - Young Adult KW - Socioeconomic Factors KW - Demography KW - Cattle KW - Child KW - Salmonella Food Poisoning KW - Risk Factors KW - Male KW - Disease Outbreaks KW - Humans KW - Middle Aged KW - Child, Preschool KW - Salmonella KW - Adult KW - Foodborne illness KW - Salmonella KW - Social vulnerability KW - Humans KW - Disease Outbreaks KW - Male KW - Animals KW - Female KW - Salmonella Food Poisoning KW - Cattle KW - Adult KW - Salmonella Infections KW - Middle Aged KW - Child KW - Adolescent KW - Demography KW - Salmonella KW - Risk Factors KW - Young Adult KW - Child, Preschool KW - Socioeconomic Factors KW - Aged LA - eng PY - 2025 T2 - Journal of Food Protection T2 - Journal of Food Protection, 2025, v. 88, no. 1 TI - Demographic Characteristics and County-level Indicators of Social Vulnerability in Salmonellosis Outbreaks Linked to Ground Beef-United States, 2012-2018. VL - 88 UR - https://stacks.cdc.gov/view/cdc/261913 ER -
AGA Living Clinical Practice Guideline on Pharmacological Management of Moderate-to-Severe Ulcerative Colitis.

Singh, Siddharth ;

Loftus, Edward V

December 2024 | Gastroenterology, 2024, v. 167, no. 7

This American Gastroenterological Association (AGA) living guideline is intended to support practitioners in the pharmacological management of moderate-to-severe ulcerative colitis (UC).A multidisciplinary panel of content experts and guideline methodologists used the Grading of Recommendations Assessment, Development and Evaluation (GRADE) framewo ...

10/09/2026

Supporting Files

Title : AGA Living Clinical Practice Guideline on Pharmacological Management of Moderate-to-Severe Ulcerative Colitis. Personal Author(s) : Singh, Siddharth;Loftus, Edward V;Limketkai, Berkeley N.;Haydek, John P.;Agrawal, Manasi;Scott, Frank I.;Ananthakrishnan, Ashwin N.; Published Date : December 2024 Pages in Document : 1307-1343 (59 pdf pages) Source : Gastroenterology, 2024, v. 167, no. 7 DOI : https://doi.org/10.1053/j.gastro.2024.10.001 Journal Title : Gastroenterology
Singh, S., Loftus, E. V., Limketkai, B. N., Haydek, J. P., Agrawal, M., Scott, F. I., & Ananthakrishnan, A. N. (2024). AGA Living Clinical Practice Guideline on Pharmacological Management of Moderate-to-Severe Ulcerative Colitis. Gastroenterology, 167(7). https://doi.org/10.1053/j.gastro.2024.10.001

Singh, Siddharth, Edward V Loftus, Berkeley N. Limketkai, John P. Haydek, Manasi Agrawal, Frank I. Scott, and Ashwin N. Ananthakrishnan. "AGA Living Clinical Practice Guideline on Pharmacological Management of Moderate-to-Severe Ulcerative Colitis." Gastroenterology 167, no. 7 (2024). https://doi.org/10.1053/j.gastro.2024.10.001.

Singh, Siddharth, et al. "AGA Living Clinical Practice Guideline on Pharmacological Management of Moderate-to-Severe Ulcerative Colitis." Gastroenterology, vol. 167, no. 7, 2024. Stacks. https://doi.org/10.1053/j.gastro.2024.10.001.
Export RIS Citation Information. TY - Journal Article AU - Singh, Siddharth AU - Loftus, Edward V AU - Limketkai, Berkeley N. AU - Haydek, John P. AU - Agrawal, Manasi AU - Scott, Frank I. AU - Ananthakrishnan, Ashwin N. AB - This American Gastroenterological Association (AGA) living guideline is intended to support practitioners in the pharmacological management of moderate-to-severe ulcerative colitis (UC). AB - A multidisciplinary panel of content experts and guideline methodologists used the Grading of Recommendations Assessment, Development and Evaluation (GRADE) framework to prioritize clinical questions, identify patient-centered outcomes, conduct an evidence synthesis, and develop recommendations on the pharmacological management of moderate-to-severe UC. AB - The AGA guideline panel made 14 recommendations. In adult outpatients with moderate-to-severe UC, the AGA recommends the use of infliximab, golimumab, vedolizumab, tofacitinib, upadacitinib, ustekinumab, ozanimod, etrasimod, risankizumab, and guselkumab, and suggests the use of adalimumab, filgotinib, and mirikizumab over no treatment. In patients who are naïve to advanced therapies, the AGA suggests using a higher-efficacy medication (eg, infliximab, vedolizumab, ozanimod, etrasimod, upadacitinib, risankizumab, and guselkumab) or an intermediate-efficacy medication (eg, golimumab, ustekinumab, tofacitinib, filgotinib, and mirikizumab) rather than a lower-efficacy medication (eg, adalimumab). In patients who have previously been exposed to 1 or more advanced therapies, particularly tumor necrosis factor (TNF)-α antagonists, the AGA suggests using a higher-efficacy medication (eg, tofacitinib, upadacitinib, and ustekinumab) or an intermediate-efficacy medication (eg, filgotinib, mirikizumab, risankizumab, and guselkumab) rather than a lower-efficacy medication (eg, adalimumab, vedolizumab, ozanimod, and etrasimod). In adult outpatients with moderate-to-severe UC, the AGA suggests against using thiopurine monotherapy for induction of remission, but suggests using thiopurine monotherapy over no treatment for maintenance of (typically corticosteroid-induced) remission. The AGA suggests against using methotrexate monotherapy, for induction or maintenance of remission. In adult outpatients with moderate-to-severe UC, the AGA suggests the use of infliximab, adalimumab, and golimumab in combination with an immunomodulator over corresponding monotherapy. However, the AGA makes no recommendation in favor of, or against, the use of non-TNF antagonist biologics in combination with an immunomodulator over non-TNF biologic alone. In patients with UC who are in corticosteroid-free clinical remission for at least 6 months on combination therapy of TNF antagonists and an immunomodulator, the AGA suggests against withdrawal of TNF antagonists, but makes no recommendation in favor of, or against, withdrawing immunomodulators. In adult outpatients with moderate-to-severe UC, who have failed 5-aminosalicylates, and have escalated to therapy with immunomodulators or advanced therapies, the AGA suggests stopping 5-aminosalicylates. Finally, in adult outpatients with moderate-severe UC, the AGA suggests early use of advanced therapies and/or immunomodulator therapy, rather than gradual step-up after failure of 5-aminosalicylates. The panel also proposed key implementation considerations for optimal use of these medications and identified several knowledge gaps and areas for future research. AB - This guideline provides a comprehensive, patient-centered approach to the pharmacological management of patients with moderate-to-severe UC. AB - Author manuscript AN - cdc:261912 C4 - PMC12162142 DO - https://doi.org/10.1053/j.gastro.2024.10.001 IS - 7 J2 - Gastroenterology KW - Drug Therapy, Combination KW - Severity of Illness Index KW - Treatment Outcome KW - Colitis, Ulcerative KW - Evidence-Based Medicine KW - Gastroenterology KW - Remission Induction KW - Consensus KW - Gastrointestinal Agents KW - Humans KW - Societies, Medical KW - Inflammatory bowel disease KW - network meta-analysis KW - evidence synthesis KW - positioning KW - Humans KW - Colitis, Ulcerative KW - Severity of Illness Index KW - Gastrointestinal Agents KW - Gastroenterology KW - Treatment Outcome KW - Remission Induction KW - Evidence-Based Medicine KW - Drug Therapy, Combination KW - Societies, Medical KW - Consensus LA - eng PY - 2024 T2 - Gastroenterology T2 - Gastroenterology, 2024, v. 167, no. 7 TI - AGA Living Clinical Practice Guideline on Pharmacological Management of Moderate-to-Severe Ulcerative Colitis. VL - 167 UR - https://stacks.cdc.gov/view/cdc/261912 ER -
The Co-receptor Neuropilin-1 Enhances Proliferation in Inv(16) Acute Myeloid Leukemia Via VEGF Signaling.

Hegde, Mahesh ;

Ahmad, Mohd H.

February 2025 | Leukemia, 2025, v. 39, no. 2

Oncogenic programs regulate the proliferation and maintenance of cancer stem cells, and can define pharmacologic dependencies. In acute myeloid leukemia (AML) with the chromosome inversion 16 (inv(16)), the fusion oncoprotein CBFβ::MYH11 regulates pathways associated with leukemia stem cell activity. Here we demonstrate that expression of Neuropili ...

10/09/2026

Supporting Files

Title : The Co-receptor Neuropilin-1 Enhances Proliferation in Inv(16) Acute Myeloid Leukemia Via VEGF Signaling. Personal Author(s) : Hegde, Mahesh;Ahmad, Mohd H.;Lazaro, Roger Mulet;Sugita, Mayumi;Li, Rui;Hu, Kai;Gebhard, Claudia;Guzman, Monica L.;Bushweller, John H.;Zhu, Lihua J.;Brehm, Michael;Wolfe, Scot A.;Delwel, Ruud;Castilla, Lucio H.; Published Date : February 2025 Pages in Document : 360-370 (25 pdf pages) Source : Leukemia, 2025, v. 39, no. 2 DOI : https://doi.org/10.1038/s41375-024-02471-9 Journal Title : Leukemia
Hegde, M., Ahmad, M. H., Lazaro, R. M., Sugita, M., Li, R., Hu, K., Gebhard, C., Guzman, M. L., Bushweller, J. H., Zhu, L. J., Brehm, M., Wolfe, S. A., Delwel, R., & Castilla, L. H. (2025). The Co-receptor Neuropilin-1 Enhances Proliferation in Inv(16) Acute Myeloid Leukemia Via VEGF Signaling. Leukemia, 39(2). https://doi.org/10.1038/s41375-024-02471-9

Hegde, Mahesh, Mohd H. Ahmad, Roger Mulet Lazaro, Mayumi Sugita, Rui Li, Kai Hu, and Claudia Gebhard, et al.. "The Co-receptor Neuropilin-1 Enhances Proliferation in Inv(16) Acute Myeloid Leukemia Via VEGF Signaling." Leukemia 39, no. 2 (2025). https://doi.org/10.1038/s41375-024-02471-9.

Hegde, Mahesh, et al. "The Co-receptor Neuropilin-1 Enhances Proliferation in Inv(16) Acute Myeloid Leukemia Via VEGF Signaling." Leukemia, vol. 39, no. 2, 2025. Stacks. https://doi.org/10.1038/s41375-024-02471-9.
Export RIS Citation Information. TY - Journal Article AU - Hegde, Mahesh AU - Ahmad, Mohd H. AU - Lazaro, Roger Mulet AU - Sugita, Mayumi AU - Li, Rui AU - Hu, Kai AU - Gebhard, Claudia AU - Guzman, Monica L. AU - Bushweller, John H. AU - Zhu, Lihua J. AU - Brehm, Michael AU - Wolfe, Scot A. AU - Delwel, Ruud AU - Castilla, Lucio H. AB - Oncogenic programs regulate the proliferation and maintenance of cancer stem cells, and can define pharmacologic dependencies. In acute myeloid leukemia (AML) with the chromosome inversion 16 (inv(16)), the fusion oncoprotein CBFβ::MYH11 regulates pathways associated with leukemia stem cell activity. Here we demonstrate that expression of Neuropilin-1 (NRP1) is regulated by the fusion oncoprotein, and promotes AML expansion. Mechanistically, we show that the NRP1 locus has open chromatin in inv(16) AML, and that CBFβ::MYH11 modulates the local function of the transcription factors ERG, GATA2 and RUNX1 to sustain NRP1 levels. We found that ERG activates NRP1 expression, and that CBFβ::MYH11 knockdown represses ERG expression, thereby allowing the repressive activity of GATA2/RUNX1 at three NRP1 enhancers. Functionally, we demonstrate that NRP1 enhances the expansion of leukemic cells in vitro and in mice, and that this activity is dependent on its VEGFR-associated FV/FVIII domain. Finally, we show that treatment with VEGF inhibitor axitinib reduces AML cell growth and delays median leukemia latency in vivo. Our findings reveal that the NRP1/VEGF axis mediates proliferation in inv(16) AML blasts, and suggest that targeting NRP1 function could be promising in combination AML therapy. AB - Author manuscript AN - cdc:261911 C4 - PMC12133020 DO - https://doi.org/10.1038/s41375-024-02471-9 IS - 2 J2 - Leukemia KW - Animals KW - Cell Line, Tumor KW - Signal Transduction KW - Neuropilin-1 KW - Chromosome Inversion KW - Cell Proliferation KW - Oncogene Proteins, Fusion KW - Chromosomes, Human, Pair 16 KW - Leukemia, Myeloid, Acute KW - Transcriptional Regulator ERG KW - Humans KW - Vascular Endothelial Growth Factor A KW - Mice KW - Neuropilin-1 KW - Leukemia, Myeloid, Acute KW - Humans KW - Cell Proliferation KW - Animals KW - Mice KW - Signal Transduction KW - Vascular Endothelial Growth Factor A KW - Chromosome Inversion KW - Oncogene Proteins, Fusion KW - Chromosomes, Human, Pair 16 KW - Transcriptional Regulator ERG KW - Cell Line, Tumor LA - eng PY - 2025 T2 - Leukemia T2 - Leukemia, 2025, v. 39, no. 2 TI - The Co-receptor Neuropilin-1 Enhances Proliferation in Inv(16) Acute Myeloid Leukemia Via VEGF Signaling. VL - 39 UR - https://stacks.cdc.gov/view/cdc/261911 ER -
Prevalence of Pediatric Inflammatory Bowel Disease in the United States: Pooled Estimates From Three Administrative Claims Data Sources.

Kappelman, Michael D. ;

Brensinger, Colleen

May 2025 | Gastroenterology, 2025, v. 168, no. 5

The worldwide prevalence of Crohn's disease (CD) and ulcerative colitis (UC), collectively known as inflammatory bowel diseases (IBD), has increased throughout the last several decades.1,2 Pediatric IBD (PIBD), a distinct clinical entity with a more extensive anatomic distribution and more aggressive natural history than adult IBD, has historically ...

10/09/2026

Supporting Files

Title : Prevalence of Pediatric Inflammatory Bowel Disease in the United States: Pooled Estimates From Three Administrative Claims Data Sources. Personal Author(s) : Kappelman, Michael D.;Brensinger, Colleen;Parlett, Lauren E.;Hurtado-Lorenzo, Andres;Lewis, James D.; Published Date : May 2025 Pages in Document : 980-982 (6 pdf pages) Source : Gastroenterology, 2025, v. 168, no. 5 DOI : https://doi.org/10.1053/j.gastro.2024.11.004 Journal Title : Gastroenterology
Kappelman, M. D., Brensinger, C., Parlett, L. E., Hurtado-Lorenzo, A., & Lewis, J. D. (2025). Prevalence of Pediatric Inflammatory Bowel Disease in the United States: Pooled Estimates From Three Administrative Claims Data Sources. Gastroenterology, 168(5). https://doi.org/10.1053/j.gastro.2024.11.004

Kappelman, Michael D., Colleen Brensinger, Lauren E. Parlett, Andres Hurtado-Lorenzo, and James D. Lewis. "Prevalence of Pediatric Inflammatory Bowel Disease in the United States: Pooled Estimates From Three Administrative Claims Data Sources." Gastroenterology 168, no. 5 (2025). https://doi.org/10.1053/j.gastro.2024.11.004.

Kappelman, Michael D., et al. "Prevalence of Pediatric Inflammatory Bowel Disease in the United States: Pooled Estimates From Three Administrative Claims Data Sources." Gastroenterology, vol. 168, no. 5, 2025. Stacks. https://doi.org/10.1053/j.gastro.2024.11.004.
Export RIS Citation Information. TY - Journal Article AU - Kappelman, Michael D. AU - Brensinger, Colleen AU - Parlett, Lauren E. AU - Hurtado-Lorenzo, Andres AU - Lewis, James D. AB - The worldwide prevalence of Crohn's disease (CD) and ulcerative colitis (UC), collectively known as inflammatory bowel diseases (IBD), has increased throughout the last several decades.1,2 Pediatric IBD (PIBD), a distinct clinical entity with a more extensive anatomic distribution and more aggressive natural history than adult IBD, has historically been considered a rare disease. The prevalence of PIBD in North America is high compared to other continents, yet nationally representative United States (U.S.) estimates are few3 with even fewer estimates of the racial and geographic distribution of disease.4 We recently defined the prevalence of physician-diagnosed IBD in the United States in a nationally representative population by pooling data from public and private health plans.5 In this report, we further describe the prevalence of PIBD and distribution across age, sex, region, and race. AB - Author manuscript AN - cdc:261910 C4 - PMC12018129 DO - https://doi.org/10.1053/j.gastro.2024.11.004 IS - 5 J2 - Gastroenterology KW - Colitis, Ulcerative KW - Prevalence KW - Physicians KW - Rare Diseases KW - Colitis, Ulcerative KW - Prevalence KW - Rare Diseases KW - Physicians LA - eng PY - 2025 T2 - Gastroenterology T2 - Gastroenterology, 2025, v. 168, no. 5 TI - Prevalence of Pediatric Inflammatory Bowel Disease in the United States: Pooled Estimates From Three Administrative Claims Data Sources. VL - 168 UR - https://stacks.cdc.gov/view/cdc/261910 ER -
Lipid Nanoparticle-mediated MRNA Delivery to CD34 Cells in Rhesus Monkeys.

Kim, Hyejin ;

Zenhausern, Ryan

November 2025 | Nature Biotechnology, 2025, v. 43, no. 11

Transplantation of ex vivo engineered hematopoietic stem cells (HSCs) can lead to robust clinical responses but carries risks of adverse events from bone marrow mobilization, chemotherapy conditioning and other factors. HSCs have been modified in vivo using lipid nanoparticles (LNPs) decorated with targeting moieties, which increases manufacturing ...

10/09/2026

Supporting Files

Title : Lipid Nanoparticle-mediated MRNA Delivery to CD34 Cells in Rhesus Monkeys. Personal Author(s) : Kim, Hyejin;Zenhausern, Ryan;Gentry, Kara;Lian, Liming;Huayamares, Sebastian G.;Radmand, Afsane;Loughrey, David;Podilapu, Ananda;Hatit, Marine Z.C.;Ni, Huanzhen;Li, Andrea;Shajii, Aram;Peck, Hannah E.;Han, Keyi;Hua, Xuanwen;Jia, Shu;Martinez, Michele;Lee, Charles;Santangelo, Philip J.;Tarantal, Alice;Dahlman, James E.; Published Date : November 2025 Pages in Document : 1813-1820 (25 pdf pages) Source : Nature Biotechnology, 2025, v. 43, no. 11 DOI : https://doi.org/10.1038/s41587-024-02470-2 Journal Title : Nature Biotechnology
Kim, H., Zenhausern, R., Gentry, K., Lian, L., Huayamares, S. G., Radmand, A., Loughrey, D., Podilapu, A., Hatit, M. Z., Ni, H., Li, A., Shajii, A., Peck, H. E., Han, K., Hua, X., Jia, S., Martinez, M., Lee, C., Santangelo, P. J., ... Dahlman, J. E. (2025). Lipid Nanoparticle-mediated MRNA Delivery to CD34 Cells in Rhesus Monkeys. Nature Biotechnology, 43(11). https://doi.org/10.1038/s41587-024-02470-2

Kim, Hyejin, Ryan Zenhausern, Kara Gentry, Liming Lian, Sebastian G. Huayamares, Afsane Radmand, and David Loughrey, et al.. "Lipid Nanoparticle-mediated MRNA Delivery to CD34 Cells in Rhesus Monkeys." Nature Biotechnology 43, no. 11 (2025). https://doi.org/10.1038/s41587-024-02470-2.

Kim, Hyejin, et al. "Lipid Nanoparticle-mediated MRNA Delivery to CD34 Cells in Rhesus Monkeys." Nature Biotechnology, vol. 43, no. 11, 2025. Stacks. https://doi.org/10.1038/s41587-024-02470-2.
Export RIS Citation Information. TY - Journal Article AU - Kim, Hyejin AU - Zenhausern, Ryan AU - Gentry, Kara AU - Lian, Liming AU - Huayamares, Sebastian G. AU - Radmand, Afsane AU - Loughrey, David AU - Podilapu, Ananda AU - Hatit, Marine Z.C. AU - Ni, Huanzhen AU - Li, Andrea AU - Shajii, Aram AU - Peck, Hannah E. AU - Han, Keyi AU - Hua, Xuanwen AU - Jia, Shu AU - Martinez, Michele AU - Lee, Charles AU - Santangelo, Philip J. AU - Tarantal, Alice AU - Dahlman, James E. AB - Transplantation of ex vivo engineered hematopoietic stem cells (HSCs) can lead to robust clinical responses but carries risks of adverse events from bone marrow mobilization, chemotherapy conditioning and other factors. HSCs have been modified in vivo using lipid nanoparticles (LNPs) decorated with targeting moieties, which increases manufacturing complexity. Here we screen 105 LNPs without targeting ligands for effective homing to the bone marrow in mouse. We report an LNP named LNP AB - that delivers mRNA to murine HSCs in vivo, primary human HSCs ex vivo and CD34 AB - cells in rhesus monkeys (Macaca mulatta) in vivo at doses of 0.25 and 0.4 mg kg AB - . Without mobilization and conditioning, LNP AB - can mediate delivery of mRNA to HSCs and their progenitor cells (HSPCs), as well as to the liver in rhesus monkeys, without serum cytokine activation. These data support the hypothesis that in vivo delivery to HSCs and HSPCs in nonhuman primates is feasible without targeting ligands. AB - Author manuscript AN - cdc:261909 C4 - PMC12095617 DO - https://doi.org/10.1038/s41587-024-02470-2 IS - 11 J2 - Nature Biotechnology KW - Lipids KW - Antigens, CD34 KW - Hematopoietic Stem Cells KW - Animals KW - Liposomes KW - Nanoparticles KW - Macaca mulatta KW - Humans KW - Hematopoietic Stem Cell Transplantation KW - RNA, Messenger KW - Mice KW - Animals KW - Macaca mulatta KW - Nanoparticles KW - Humans KW - Hematopoietic Stem Cells KW - Antigens, CD34 KW - Mice KW - Lipids KW - RNA, Messenger KW - Hematopoietic Stem Cell Transplantation KW - Liposomes LA - eng PY - 2025 T2 - Nature Biotechnology T2 - Nature Biotechnology, 2025, v. 43, no. 11 TI - Lipid Nanoparticle-mediated MRNA Delivery to CD34 Cells in Rhesus Monkeys. VL - 43 UR - https://stacks.cdc.gov/view/cdc/261909 ER -
Effects of Different Block Designs on Low Back and Shoulders Biomechanical Loads and Postural Stability During Crab Pot Handling.

Kia, Kiana ;

Chan, Allen

April 2025 | Applied Ergonomics, 2025, v. 124

In commercial Dungeness crab fishing vessels, the block pulls crab pots for harvesting and typically positions them to the side of vessels, rather than the sorting tables on board. Consequently, fishermen must reach outside the vessel to grab the pots, posing increased risk of musculoskeletal and fall-related injuries. To investigate the effects of ...

10/09/2026

Supporting Files

Title : Effects of Different Block Designs on Low Back and Shoulders Biomechanical Loads and Postural Stability During Crab Pot Handling. Personal Author(s) : Kia, Kiana;Chan, Allen;Salehi, Mina;Kincl, Laurel;Kim, Jeong Ho; Published Date : April 2025 Pages in Document : 104423 (28 pdf pages) Source : Applied Ergonomics, 2025, v. 124 DOI : https://doi.org/10.1016/j.apergo.2024.104423 Journal Title : Applied Ergonomics
Kia, K., Chan, A., Salehi, M., Kincl, L., & Kim, J. H. (2025). Effects of Different Block Designs on Low Back and Shoulders Biomechanical Loads and Postural Stability During Crab Pot Handling. Applied Ergonomics, 124. https://doi.org/10.1016/j.apergo.2024.104423

Kia, Kiana, Allen Chan, Mina Salehi, Laurel Kincl, and Jeong Ho Kim. "Effects of Different Block Designs on Low Back and Shoulders Biomechanical Loads and Postural Stability During Crab Pot Handling." Applied Ergonomics 124 (2025). https://doi.org/10.1016/j.apergo.2024.104423.

Kia, Kiana, et al. "Effects of Different Block Designs on Low Back and Shoulders Biomechanical Loads and Postural Stability During Crab Pot Handling." Applied Ergonomics, vol. 124, 2025. Stacks. https://doi.org/10.1016/j.apergo.2024.104423.
Export RIS Citation Information. TY - Journal Article AU - Kia, Kiana AU - Chan, Allen AU - Salehi, Mina AU - Kincl, Laurel AU - Kim, Jeong Ho AB - In commercial Dungeness crab fishing vessels, the block pulls crab pots for harvesting and typically positions them to the side of vessels, rather than the sorting tables on board. Consequently, fishermen must reach outside the vessel to grab the pots, posing increased risk of musculoskeletal and fall-related injuries. To investigate the effects of block design on these risks, 25 participants in a repeated-measures laboratory study handled a pot under two block conditions: away-from-table (conventional setting) and above-table (intervention). Low back and shoulder muscle activities, angles, moments, perceived exertion, and postural stability were measured. The results showed reduced L5/S1 and shoulder moments and angles; decreased muscle activities in the low back, shoulders, and upper extremities; and lower perceived exertion ratings and postural sway measures with the intervention. These findings indicate that positioning the pot closer to fishermen onboard could reduce the injury and fall risk associated with crab pot handling. AB - Author manuscript AN - cdc:261908 C4 - PMC12487759 DO - https://doi.org/10.1016/j.apergo.2024.104423 J2 - Applied Ergonomics KW - Weight-Bearing KW - Ships KW - Occupational Injuries KW - Young Adult KW - Postural Balance KW - Shoulder KW - Hunting KW - Lumbosacral Region KW - Male KW - Accidental Falls KW - Middle Aged KW - Humans KW - Brachyura KW - Biomechanical Phenomena KW - Adult KW - Commercial fishing KW - Musculoskeletal disorders KW - Low back stress KW - Electromyography KW - 3-D motion capture KW - Lumbosacral Region KW - Occupational Injuries KW - Hunting KW - Accidental Falls KW - Postural Balance KW - Biomechanical Phenomena KW - Brachyura KW - Ships KW - Shoulder KW - Weight-Bearing KW - Humans KW - Male KW - Young Adult KW - Adult KW - Middle Aged LA - eng PY - 2025 T2 - Applied Ergonomics T2 - Applied Ergonomics, 2025, v. 124 TI - Effects of Different Block Designs on Low Back and Shoulders Biomechanical Loads and Postural Stability During Crab Pot Handling. VL - 124 UR - https://stacks.cdc.gov/view/cdc/261908 ER -
Respiratory Function and Evaluation in Individuals With Facioscapulohumeral Muscular Dystrophy in the Muscular Dystrophy Surveillance, Tracking and Research Network.

Mathews, Katherine D ;

Suhl, Jonathan

January 2025 | Neuromuscular Disorders: NMD, 2025, v. 46

Using data from the US population-based, multisite Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet), we describe respiratory testing and insufficiency among people with facioscapulohumeral muscular dystrophy (FSHD) diagnosed during 2008-2016. We calculated frequencies and proportions for selected outpatient respiratory a ...

10/09/2026

Supporting Files

Title : Respiratory Function and Evaluation in Individuals With Facioscapulohumeral Muscular Dystrophy in the Muscular Dystrophy Surveillance, Tracking and Research Network. Personal Author(s) : Mathews, Katherine D;Suhl, Jonathan;Conway, Kristin M;Moore, Amy;Alese, Joyce T.;Butterfield, Russell J;Romitti, Paul A; Corporate Authors(s) : Muscular Dystrophy Surveillance, Tracking and Research Network (MD STARnet) Published Date : January 2025 Pages in Document : 105240 (13 pdf pages) Source : Neuromuscular Disorders: NMD, 2025, v. 46 DOI : https://doi.org/10.1016/j.nmd.2024.105240 Journal Title : Neuromuscular Disorders: NMD
Mathews, K. D., Suhl, J., Conway, K. M., Moore, A., Alese, J. T., Butterfield, R. J., & Romitti, P. A. (2025). Respiratory Function and Evaluation in Individuals With Facioscapulohumeral Muscular Dystrophy in the Muscular Dystrophy Surveillance, Tracking and Research Network. Neuromuscular Disorders: NMD, 46. https://doi.org/10.1016/j.nmd.2024.105240

Mathews, Katherine D, Jonathan Suhl, Kristin M Conway, Amy Moore, Joyce T. Alese, Russell J Butterfield, and Paul A Romitti. "Respiratory Function and Evaluation in Individuals With Facioscapulohumeral Muscular Dystrophy in the Muscular Dystrophy Surveillance, Tracking and Research Network." Neuromuscular Disorders: NMD 46 (2025). https://doi.org/10.1016/j.nmd.2024.105240.

Mathews, Katherine D, et al. "Respiratory Function and Evaluation in Individuals With Facioscapulohumeral Muscular Dystrophy in the Muscular Dystrophy Surveillance, Tracking and Research Network." Neuromuscular Disorders: NMD, vol. 46, 2025. Stacks. https://doi.org/10.1016/j.nmd.2024.105240.
Export RIS Citation Information. TY - Journal Article AU - Mathews, Katherine D AU - Suhl, Jonathan AU - Conway, Kristin M AU - Moore, Amy AU - Alese, Joyce T. AU - Butterfield, Russell J AU - Romitti, Paul A A2 - Muscular Dystrophy Surveillance, Tracking and Research Network (MD STARnet) AB - Using data from the US population-based, multisite Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet), we describe respiratory testing and insufficiency among people with facioscapulohumeral muscular dystrophy (FSHD) diagnosed during 2008-2016. We calculated frequencies and proportions for selected outpatient respiratory assessments (pulmonary function tests [PFTs], forced vital capacity (FVC), inspiratory/expiratory pressure, and polysomnograms) and abnormal test results. We examined frequencies by disease characteristics (FSHD type, ages of onset, non-ambulatory status, scoliosis, lordosis), obesity, and number of health encounters. Of 170 people with FSHD, 20.0% underwent PFTs during 2008-2016. Polysomnograms were infrequent (14.1%). FVC <80% predicted was recorded for 64.7% of people tested; additional respiratory outcomes were rare (<5%). Frequency of evaluations and respiratory insufficiency were higher among those with known risk factors and longer follow-up. We observed low proportions of respiratory testing among all confirmed cases of FSHD, but relatively high proportions of mild respiratory insufficiency among those tested. The higher proportions of testing among people with conditions that increase risk of respiratory complications suggest targeted monitoring. Broad implementation of the FSHD guidelines recommending all individuals receive baseline respiratory evaluation at diagnosis could identify respiratory insufficiency as a complication of FSHD. AB - Author manuscript AN - cdc:261907 C4 - PMC11911087 DO - https://doi.org/10.1016/j.nmd.2024.105240 J2 - Neuromuscular Disorders: NMD KW - Respiratory Insufficiency KW - Muscular Dystrophy, Facioscapulohumeral KW - Adolescent KW - Female KW - Aged KW - Young Adult KW - Polysomnography KW - Child KW - Respiratory Function Tests KW - Male KW - Humans KW - Middle Aged KW - Adult KW - Muscular dystrophy KW - Facioscapulohumeral respiratory insufficiency KW - Guidelines KW - Surveillance KW - Humans KW - Muscular Dystrophy, Facioscapulohumeral KW - Male KW - Female KW - Respiratory Function Tests KW - Adult KW - Middle Aged KW - Adolescent KW - Young Adult KW - Aged KW - Child KW - Respiratory Insufficiency KW - Polysomnography LA - eng PY - 2025 T2 - Neuromuscular Disorders: NMD T2 - Neuromuscular Disorders: NMD, 2025, v. 46 TI - Respiratory Function and Evaluation in Individuals With Facioscapulohumeral Muscular Dystrophy in the Muscular Dystrophy Surveillance, Tracking and Research Network. VL - 46 UR - https://stacks.cdc.gov/view/cdc/261907 ER -

Previous Page Previous

341 - 360 / 1970

Next Page Next

Found an issue?

Send us an email at: publishinghd@cdc.gov